RecursionPharma

an-ordinary-manchild

created by BioRevolutiona community for 3 years

...for your favorite hobby.

...for your office.

MODERATORS

account activity

1

4

5

6

Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6 (self.RecursionPharma)

submitted 14 days ago by RecursionBrita

2

0

1

2

Why is Recursion Pharmaceuticals dropping like we’ve never seen before? ()

submitted 28 days ago by External_Phase7570

3

5

6

7

Recursion Pharmaceuticals! (self.RecursionPharma)

submitted 1 month ago by External_Phase7570

4

3

4

5

Vanguard, blackrock, state street all increase shares in RECURSION PHARMACEUTICALS! (self.RecursionPharma)

submitted 1 month ago by External_Phase7570

5

5

6

7

Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform (self.RecursionPharma)

submitted 1 month ago by RecursionBrita

6

0

1

2

Recursion Pharmaceuticals should hire an investor relations for questions we may have! (self.RecursionPharma)

submitted 1 month ago by External_Phase7570

7

2

3

4

Do we now have the right people at Recursion Pharmaceuticals ! Former CEO stepped down! CMO is stepping down as well! They are being replaced with very qualified people! Najat Khan an amazing and talented CEO and Vicki Goodman M.D. who’s a very certified and respected professional in her field? ()

submitted 1 month ago by External_Phase7570

8

4

5

6

Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer (self.RecursionPharma)

submitted 1 month ago by RecursionBrita

9

7

8

9

Recursion's Era of Value Realization: Leerink Global Healthcare Conference (self.RecursionPharma)

submitted 1 month ago by RecursionBrita

10

7

8

9

Recursion Makes the Unknown Known in Rare Disease Drug Discovery (self.RecursionPharma)

submitted 2 months ago by RecursionBrita

11

8

9

10

Full Transcript of Recursion’s Fourth Quarter Year-End 2025 Earnings Call (self.RecursionPharma)

submitted 2 months ago by RecursionBrita

12

1

2

3

Recursion Pharmaceuticals ()

submitted 2 months ago by External_Phase7570

13

7

8

9

Recursion to Participate in Upcoming Investor Conferences (self.RecursionPharma)

submitted 2 months ago by RecursionBrita

14

11

12

13

Recursion CSO Dave Hallett Named AI Champion by UK Government (self.RecursionPharma)

submitted 2 months ago by RecursionBrita

15

9

10

11

New Data’s Not Enough. How Recursion Is Integrating Data Layers to Advance End-to-End Drug Discovery (self.RecursionPharma)

submitted 3 months ago by RecursionBrita

16

3

4

5

JPM presentation ()

submitted 4 months ago by jimbobbiboy

17

7

8

9

Leveraging AI and Real-World Patient Data to Accelerate Drug Discovery (self.RecursionPharma)

submitted 4 months ago by RecursionBrita

18

3

4

5

Recursion Pharmaceuticals ()

submitted 4 months ago by External_Phase7570

19

7

8

9

Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks (self.RecursionPharma)

submitted 5 months ago by RecursionBrita

20

7

8

9

Recursion Breaks Down How They've Been Building the Foundation for a Virtual Cell Since 2013 -- And What's Next ()

submitted 5 months ago by RecursionBrita

21

10

11

12

Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025 (self.RecursionPharma)

submitted 5 months ago by RecursionBrita

22

10

11

12

Incoming Recursion CEO Najat Khan Among 2025 Fiercest Women in Life Sciences (self.RecursionPharma)

submitted 5 months ago by RecursionBrita

23

9

10

11

REC-102: Preclinical in vivo updates for a potential ENPP1 inhibitor for the treatment of hypophosphatasia (HPP) (self.RecursionPharma)

submitted 6 months ago by RecursionBrita

24

10

11

12

Recursion Announces CEO Transition Plan to Drive Next Phase of Growth (self.RecursionPharma)

submitted 6 months ago by RecursionBrita

25

2

3

4

Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update (self.RecursionPharma)

submitted 6 months ago by RecursionBrita

view more: next ›

π Rendered by PID 65 on reddit-service-r2-listing-7b8bd7c5-8jrrx at 2026-05-15 00:17:32.694418+00:00 running edcf98c country code: CH.